药物发现中的ChatGPT:用聊天机器人开发抗可卡因成药物的案例研究
Rui Wang1, Hongsong Feng1, Guo-Wei Wei1,2,3
1Department of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States.
Journal of chemical information and modeling
|November 13, 2023
概括
本研究探讨使用ChatGPT (生成预训练变压器4) 加速抗可卡因成药物发现. 人工智能帮助研究人员设计最佳的类似药物的分子,增强治疗创新.
科学领域:
- 药理学中的人工智能
- 药物发现和开发 药物发现和开发
- 计算化学的计算化学
背景情况:
- 集成先进的AI,特别是像ChatGPT这样的大型语言模型,在科学研究中带来了新的机遇和挑战.
- 人工智能在药物发现中的应用是一个不断发展的领域,有可能简化复杂的过程.
研究的目的:
- 研究ChatGPT (GPT-4) 作为开发抗可卡因成药物的虚拟指南的创新应用.
- 探索人工智能聊天机器人的潜力,为生成药物候选模型提供战略和方法的见解.
主要方法:
- 利用GPT-4作为人工智能助理指导研究人员开发药物候选者的生成模型.
- 专注于为抗可卡因成治疗产生具有理想药理性质的最佳类药物分子.
主要成果:
- 通过利用ChatGPT的能力来增强制药解决方案的设计和开发,展示了对药物发现的新方法.
- 展示了人类专业知识和人工智能协助加快识别潜在候选药物的协同作用.
结论:
- 像ChatGPT这样的AI驱动的聊天机器人可以在药物发现过程中充当有价值的促进者,引导研究人员走向创新的方法.
- 这项研究倡导人工智能在改变治疗创新和药物开发方面的变革性作用.
更多相关视频
08:22Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference
Published on: July 30, 2013
18.6K
09:43Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
Published on: October 5, 2021
2.5K
相关概念视频
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Drug Abuse and Addiction: Pharmacological Phenomena
489
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
489
Structure-Activity Relationships and Drug Design
734
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
734
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
